Cocaine and amphetamine regulated transcript (CART) gene in the comorbidity of schizophrenia with alcohol use disorders and nicotine dependence

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 6, 2010, Pages 834-

  Busto, Amaya ^a   Souza, Renan P ^a,b   Lobo, Daniela S S ^a,b   Shaikh, Sajid A ^a   Zawertailo, Laurie A ^a,b   Busto, Usoa E ^a,b   Kennedy, James L ^a,b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Addiction; Alcohol abuse; Alcohol dependence; Neuropeptide; Polymorphism; Psychosis

Indexed keywords

COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE;

ADULT; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; CAUCASIAN; COMORBIDITY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; SCHIZOPHRENIA; TOBACCO DEPENDENCE;

EID: 77955055325     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.03.030     Document Type: Article

References (20)

1. Ardlie K., Liu-Cordero S.N., Eberle M.A., Daly M., Barrett J., Winchester E., et al. Lower-than-expected linkage disequilibrium between tightly linked markers in humans suggests a role for gene conversion. Am J Hum Genet 2001, 69:582-589.
2. Bellack A.S., Bennett M.E., Gearon J.S., Brown C.H., Yang Y. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness. Arch Gen Psychiatry 2006, 63:426-432.
3. Dayas C.V., McGranahan T.M., Martin-Fardon R., Weiss F. Stimuli linked to ethanol availability activate hypothalamic CART and orexin neurons in a reinstatement model of relapse. Biol Psychiatry 2008, 63:152-157.
4. de Leon J., Diaz F.J. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res 2005, 76:135-157.
5. Dome P., Lazary J., Kalapos M.P., Rihmer Z. Smoking, nicotine and neuropsychiatric disorders. Neurosci Biobehav Rev 2010, 34:295-342.
6. Henquet C., Di Forti M., Morrison P., Kuepper R., Murray R.M. Gene-environment interplay between cannabis and psychosis. Schizophr Bull 2008, 34:1111-1121.
7. Hirata Y., Souza R.P., Lieberman J.A., Meltzer H.Y., Kennedy J.L. Lack of association between HTR4 gene polymorphisms and schizophrenia in case-control and family-based samples. Psychiatry Res 2010, 175:176-178.
8. Hunter R.G., Kuhar M.J. CART peptides as targets for CNS drug development. Curr Drug Targets CNS Neurol Disord 2003, 2:201-205.
9. Jung S.K., Hong M.S., Suh G.J., Jin S.Y., Lee H.J., Kim B.S., et al. Association between polymorphism in intron 1 of cocaine- and amphetamine-regulated transcript gene with alcoholism, but not with bipolar disorder and schizophrenia in Korean population. Neurosci Lett 2004, 365:54-57.
10. Koskinen J., Lohonen J., Koponen H., Isohanni M., Miettunen J. Prevalence of alcohol use disorders in schizophrenia-a systematic review and meta-analysis. Acta Psychiatr Scand 2009, 120:85-96.
11. Kramer P.R., Kramer S.F., Marr K., Guan G., Wellman P.J., Bellinger L.L. Nicotine administration effects on feeding and cocaine-amphetamine-regulated transcript (CART) expression in the hypothalamus. Regul Pept 2007, 138:66-73.
12. Lahiri D.K., Nurnberger J.I. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991, 19:5444.
13. Lohoff F.W., Bloch P.J., Weller A.E., Nall A.H., Doyle G.A., Buono R.J., et al. Genetic variants in the cocaine- and amphetamine-regulated transcript gene (CARTPT) and cocaine dependence. Neurosci Lett 2008, 440:280-283.
14. Manolio T.A., Collins F.S., Cox N.J., Goldstein D.B., Hindorff L.A., Hunter D.J., et al. Finding the missing heritability of complex diseases. Nature 2009, 461:747-753.
15. McGuffin P., Gottesman I.I. Risk factors for schizophrenia. N Engl J Med 1999, 341:370-371.
16. Morio A., Ujike H., Nomura A., Tanaka Y., Morita Y., Otani K., et al. No association between CART (cocaine- and amphetamine-regulated transcript) gene and methamphetamine dependence. Ann N Y Acad Sci 2006, 1074:411-417.
17. Souza R.P., Tampakeras M., Basile V., Shinkai T., Rosa D.V., Potkin S., et al. Lack of association of GPX1 and MnSOD genes with symptom severity and response to clozapine treatment in schizophrenia subjects. Hum Psychopharmacol 2009, 24:676-679.
18. Souza R.P., de Luca V., Meltzer H.Y., Lieberman J.A., Kennedy J.L. Influence of serotonin 3A and 3B receptor genes on clozapine treatment response in schizophrenia. Pharmacogenet Genomics 2010, 20:274-276.
19. Souza R.P., Romano-Silva M.A., Lieberman J.A., Meltzer H.Y., Macneil L.T., Culotti JG, et al. Genetic association of the GDNF alpha-receptor genes with schizophrenia and clozapine response. J Psychiatr Res 2010, 44:700-706.
20. Tandon R., Keshavan M.S., Nasrallah H.A. Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology. Schizophr Res 2008, 102:1-18.